PACS Group (NYSE:PACS) Director Sells $223,767.96 in Stock

PACS Group, Inc. (NYSE:PACS) Director Mark Hancock sold 4,966 shares of the company’s stock in a transaction on Thursday, July 9th. The stock was sold at an average price of $45.06, for a total value of $223,767.96. Following the sale, the director owned 53,920,512 shares of the company’s stock, valued at approximately $2,429,658,270.72. This represents a 0.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

• On Wednesday, July 8th, Mark Hancock sold 20,338 shares of PACS Group stock. The shares were sold at an average price of $45.07, for a total value of $916,633.66.
• On Monday, July 6th, Mark Hancock sold 142,163 shares of PACS Group stock. The shares were sold at an average price of $45.33, for a total value of $6,444,248.79.
• On Thursday, July 2nd, Mark Hancock sold 12,825 shares of PACS Group stock. The stock was sold at an average price of $45.01, for a total value of $577,253.25.
• On Wednesday, July 1st, Mark Hancock sold 6,080 shares of PACS Group stock. The stock was sold at an average price of $45.02, for a total value of $273,721.60.
• On Friday, June 26th, Mark Hancock sold 61,931 shares of PACS Group stock. The shares were sold at an average price of $40.50, for a total value of $2,508,205.50.
• On Thursday, June 25th, Mark Hancock sold 138,069 shares of PACS Group stock. The shares were sold at an average price of $40.33, for a total value of $5,568,322.77.
• On Wednesday, June 17th, Mark Hancock sold 63,680 shares of PACS Group stock. The shares were sold at an average price of $35.31, for a total value of $2,248,540.80.
• On Tuesday, June 16th, Mark Hancock sold 83,066 shares of PACS Group stock. The stock was sold at an average price of $35.90, for a total transaction of $2,982,069.40.
• On Monday, June 15th, Mark Hancock sold 153,254 shares of PACS Group stock. The shares were sold at an average price of $36.34, for a total transaction of $5,569,250.36.

PACS Group Stock Performance

PACS stock opened at $43.24 on Monday. PACS Group, Inc. has a one year low of $7.50 and a one year high of $45.89. The firm has a market cap of $6.84 billion, a price-to-earnings ratio of 27.72, a PEG ratio of 1.29 and a beta of -0.08. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.99 and a current ratio of 0.99. The firm has a 50-day simple moving average of $38.13 and a two-hundred day simple moving average of $36.94.

PACS Group (NYSE:PACS) last issued its quarterly earnings data on Monday, May 11th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.36 billion. PACS Group had a net margin of 4.49% and a return on equity of 26.47%. On average, equities analysts forecast that PACS Group, Inc. will post 2.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on PACS shares. Wall Street Zen raised PACS Group from a “buy” rating to a “strong-buy” rating in a research report on Monday, June 15th. Truist Financial boosted their target price on PACS Group from $50.00 to $52.00 and gave the stock a “buy” rating in a research note on Monday, May 18th. UBS Group boosted their target price on PACS Group from $50.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday. Finally, Oppenheimer increased their price target on PACS Group from $42.00 to $48.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, PACS Group currently has an average rating of “Moderate Buy” and a consensus price target of $50.60.

Institutional Investors Weigh In On PACS Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. Hollencrest Capital Management acquired a new position in shares of PACS Group in the 4th quarter valued at $27,000. Financial Management Professionals Inc. lifted its position in PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after acquiring an additional 235 shares during the period. Quarry LP lifted its position in PACS Group by 79.5% during the 3rd quarter. Quarry LP now owns 2,388 shares of the company’s stock worth $33,000 after acquiring an additional 1,058 shares during the period. Larson Financial Group LLC grew its stake in PACS Group by 127.0% during the 4th quarter. Larson Financial Group LLC now owns 1,094 shares of the company’s stock valued at $42,000 after purchasing an additional 612 shares during the last quarter. Finally, KBC Group NV purchased a new stake in PACS Group during the 1st quarter valued at about $42,000.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.